Top Articles

In this nice paper, recently published in the European Journal of Neurology, the authors reviewed neurological manifestations in patients with COVID-19 and the possible neuro-invasive mechanisms of Sars-CoV-2.

In this paper, the authors report three patients infected with SARS-CoV-2 who developed generalised myoclonus. Two men and one woman (aged 63 to 88) presented with mild hypersomnia and generalised myoclonus following onset of the so-called “inflammatory” phase of COVID-19 infection.

In this article, just published in Lancet, the authors report an analysis of multinational registry data on the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19.

In this article, just published in the New England Journal of Medicine, Beigel et al. conducted a double-blind, randomised, placebo-controlled trial of intravenous remdesivir in adults hospitalised with Covid-19 with evidence of lower respiratory tract involvement.

It is with great pride and gratitude that we thank everyone who took part in the 6th Annual Congress of the European Academy of Neurology last week. This was the first ever EAN Virtual Congress and truly a pioneering event in terms of neurology and academic conferences more widely.

For June 2020, we have selected: Mao L. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China JAMA

The 6th Annual Congress of the European Academy of Neurology and first Virtual Congress was a record-breaking event, with more than 42,502 registered participants. This makes it the biggest neurology event in history! With more than 5,233 days of combined… Continue Reading

On the last day of the congress, the EAN Scientific Panel of dementia and cognitive disorders organized a symposium with the aim to examine the neuropathological features of non-Alzheimer pathology in the elderly

This interesting session covering the updates on acute stroke treatments started with a lecture by Dr Sandset from Norway. She discussed the last evidence for on- and off-label treatment in intravenous thrombolysis, and started her lecture reminding that all evidence indicate that time is critical in the treatment of stroke. First, the results of the recent WAKE UP trial have been discussed, in which it was demonstrated that the treatment with intravenous alteplase was associated with a favorable outcome in patients with stroke with an unknown time of onset in the presence of MRI features suggesting recent cerebral infarction.

On 25th May 2020, the first virtual general assembly of the Resident and Research Fellow Section (RRFS) of the EAN took place. The assembly received broad participation from RRFS members who were interested in gaining insight into the annual report as well as the new Treasurer elections.

Symposium 6 shed light on the autonomic disorders in a broad range of neurological and paraphysiological conditions through either pre-clinical and clinical studies as well as novel treatment approaches.

On the first day of the congress, more than 3000 participants joined the symposium organised by EAN and IFCN-EMEAC. In the first lecture prof. Walter Paulus from Germanypresented “Entrainment of brain function: bridging transcranial electric and magnetic stimulation”. At the beginning of his lecture, he explained some essentials of transcranial electric (tDCS) and transcranial magnetic (TMS) stimulation.

“Challenges for Women in Neurology” has been an amazing session centred on the challenges that women have to face in their careers as neurologists and researchers. The session was covered with three excellent and touching talks by Professors of Neurology and was moderated by Prof. Elena Moro and Dr. Antonella Macerollo.

The European Academy of Neurology has installed three series of named lectures. They are named after three outstanding European neurologists and are reserved for outstanding active basic and clinical scientists. The awardees are selected by the EAN.

This joint session from EAN and European Headache Federation addressed a hot topic in the headache field. The speakers mentioned the past, present and future of the acute medications and gave some clues for managing special populations, such as childhood, pregnancy and elderly patients.